You just read:

Lilly's REYVOW™ (lasmiditan) C-V, the First and Only Medicine in a New Class of Acute Treatment for Migraine (ditan), Now Available for Prescription

News provided by

Eli Lilly & Company

Jan 31, 2020, 10:43 ET